Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × Sunitinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 18 Gastrointestinal Stromal Tumors 10 Neoplasms 5 Neoplasm Metastasis 4 Multiple Myeloma 4 Kidney Neoplasms 4 Urologic Neoplasms 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteosarcoma 2 Meningioma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Kidney Diseases 2 Gastrointestinal Neoplasms 2 Carcinoma, Hepatocellular 2 Carcinoma 2 Adenoma, Islet Cell 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Solid Tumors Refractory to Standard Therapy 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1

Interventions

Cyclophosphamide 7 Etoposide 5 Prednisone 4 Doxorubicin 4 Vincristine 3 romidepsin 2 pembrolizumab 2 etoposide phosphate 2 duvelisib 2 Melphalan 2 Brentuximab Vedotin 2 Azacitidine 2 10-propargyl-10-deazaaminopterin 2 tazemetostat 1 sodium-iodide symporter 1 ruxolitinib 1 prednylidene 1 glofitamab 1 fludarabine phosphate 1 fludarabine 1 deltacortene 1 cemiplimab 1 brincidofovir 1 belinostat 1 X-Rays 1 Whole-Body Irradiation 1 Valganciclovir 1 Therapeutics 1 Tacrolimus 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡